Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progression
免疫代谢治疗靶向揭示了己糖激酶 2 剂量对小胶质细胞活化和阿尔茨海默病进展的关键依赖
期刊:Cell Reports
影响因子:7.5
doi:10.1016/j.celrep.2024.114488
Juan F Codocedo, Claudia Mera-Reina, Peter Bor-Chian Lin, Paul B Fallen, Shweta S Puntambekar, Brad T Casali, Nur Jury-Garfe, Pablo Martinez, Cristian A Lasagna-Reeves, Gary E Landreth